Executive Changes
“Four or five major acquisitions over the last few years repositioned it, a 140-year-old company, from being a B-to-B company to B-to B-to-C company. That is a major enterprise strategy shift,” says CEO Patrick Lockwood-Taylor.
“In a very siloed organization made up of a jigsaw of different companies, no one was thinking enterprise first,” says Perrigo CEO Patrick Lockwood-Taylor. “The fundamentals of running operations, brand-building, innovation, they are now as they were.”
An interactive look at recent executive-level company changes and promotions in the medical device and diagnostics industries.
Speaking to Generics Bulletin on the sidelines of the AAM’s Access! 2026 conference, IGBA chair for 2026 Jim Keon – also president of the CGPA and Biosimilars Canada – discussed IP abuses, supply challenges, biosimilar streamlining and the importance of giving the off-patent industry a global voice.
Antonio Martinez Descalzo has more than 20 years' experience in life sciences, health and nutraceutical industries, including with food and beverage giant ADM. Israeli firm has completed pilot production and is moving into full manufacturing.
An interactive look at recent executive-level company changes and promotions in the biopharma, medical device and diagnostics industries.
AHPA Awards Hero, Champion, Visionary and others at annual meeting; Kimberly-Clark’s information chief has major-merger experience; RäFoods’ marketing chief has history with CEO; and Eshbal adds VP for North America expansion.
An interactive look at recent executive-level company changes and promotions in the medical device and diagnostics industries.
Generics Bulletin brings you the most noteworthy recent appointments in the off-patent and value-added medicines space.
Sandoz has unveiled a major reorganization of its generics and biosimilars operations into two distinct businesses, bringing in Ferring and Merck veteran Armin Metzger to lead a new global biosimilars unit while at the same time assigning existing executives to generics roles.
VALR Energy names appoints chief revenue officer; CEO at Audien Hearing; Anderson retiring at NACDS; Lindora appoints president and chief medical officer; and USHR expands leadership.
An interactive look at recent executive-level company changes and promotions in the medical device and diagnostics industries.